World: DRIVe BARDA initiative / DRIVe-X
SCOPE: The Biomedical Advanced Research and Development Authority (BARDA) serves the US nation by partnering with industry to make available medical countermeasures against wide range of major threats to the health security. DRIVe (Division of Research, Innovation, and Ventures) is a bold new approach to achieving once-unthinkable solutions to health security challenges – through the power of collaboration and innovation. DRIVe PPP will provide non-dilutive and dilutive funding opportunities to Companies (DRIVe-X), VCs (Ventures V), non-for-profit third parties (LAUNCH) and regional accelerators (ACCELERATORS).
3 KEY FOCUS AREAS:
SEPSIS: new technologies to aid in restoring patients’ homeostasis.
ENACT (Early Notification to Act, Control and Treat): closing the gap between diagnosis and treatment by leveraging advanced data analytics and algorithms coupled with innovative detection modalities.
Other areas: creating universal treatment options for broad classes of pathogens, ensuring access to life-saving medical countermeasures, and transforming medical countermeasure development by eradicating animal testing (non-exhaustive).
More information available here
DRIVe EZ-BAA Notice details available here